登录 注册 会员服务 联系我们

Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction

  • Published:2021-07 Issue:7 Volume:11 Page:2059-2069
  • ISSN:2211-3835
  • Container-title:Acta Pharmaceutica Sinica B
  • language:en
  • Short-container-title:Acta Pharmaceutica Sinica B

Author:

Li Bozhao,Wei Jingyan,Di Chunzhi,Lu Zefang,Qi Feilong,Zhang Yinlong,Leong Wei Sun,Li Lele,Nie Guangjun,Li Suping

Funder

National Natural Science Foundation of China

Beijing Municipal Natural Science Foundation

National Key Research and Development Program of China

K. C. Wong Education Foundation

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference35 articles.

1. Angiogenesis in cancer, vascular, rheumatoid and other disease;Folkman;Nat Med,1995

2. Strategies for advancing cancer nanomedicine;Vikash;Nat Mater,2013

3. Generation of fusion proteins for selective occlusion of tumor vessels;Kessler;Curr Drug Discov Technol,2008

4. Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles;Li;Nat Biomed Eng,2020

5. Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis;Hu;Cancer Res,2003
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3